Hilmar Ebersbach

Hilmar Ebersbach has been Vice President for Antibody Development and Protein Engineering at ImmunOs since Oct 2022. He has more than 20 years of experience in research and development of biologics including 15 years at Novartis/NIBR in different roles with increasing responsibilities in scientific and operational leadership. Hilmar has expertise in the development of a broad range of modalities, including therapeutic and multi-specific proteins, bio-conjugates, and CAR-T and AAV based assets, and has advanced a number of therapeutic candidates from early research into clinical development in the fields immuno-oncology and autoimmune disease. Hilmar has contributed to numerous scientific publications and granted patents, completed post-doctoral training in the Plückthun lab at University of Zurich, and holds a PhD in protein engineering and a diploma in biochemistry, both from University of Halle, Germany.